Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Q3 2025 value amounting to $80000.0.

  • Arcutis Biotherapeutics' Tax Provisions changed N/A to $80000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 19340.97%. This contributed to the annual value of $647000.0 for FY2024, which is 7921.62% down from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Tax Provisions stood at $80000.0 for Q3 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Tax Provisions peaked at $3.0 million during Q3 2023, and registered a low of $25000.0 during Q4 2023.
  • In the last 3 years, Arcutis Biotherapeutics' Tax Provisions had a median value of $323000.0 in 2024 and averaged $628000.0.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 119200.0% in 2024, then tumbled by 1388.89% in 2025.
  • Arcutis Biotherapeutics' Tax Provisions (Quarter) stood at $25000.0 in 2023, then surged by 1192.0% to $323000.0 in 2024, then tumbled by 75.23% to $80000.0 in 2025.
  • Its Tax Provisions was $80000.0 in Q3 2025, compared to $342000.0 in Q2 2025 and $279000.0 in Q1 2025.